{"rows":[{"id":5975,"title":"Study participant perceptions of the relevance of therapist and study team personal psychedelic experience","authors":"Benjamin R. Lewis, Eric L. Garland, Zach Schwartz, Yitong Xin, Kevin Byrne, Kious Brent","journal":"Psychedelics","publication_date":"2026-10-03","publication_year":2026,"doi":"10.1016/j.psyche.2026.100041","pubmed_id":null,"openalex_id":"https://openalex.org/W7218519509","source_url":"https://doi.org/10.1016/j.psyche.2026.100041","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Spirituality,Randomized Controlled Trial,Healthcare Workers","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-05 01:20:20","last_checked":"2026-10-09 01:20:19","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100041","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100041","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.psyche.2026.100041","source_url":"https://doi.org/10.1016/j.psyche.2026.100041","doi":"10.1016/j.psyche.2026.100041","pmid":"","publication_date":"2026-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5967,"title":"The New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy","authors":"Borbón Diego","journal":"Psychedelics","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100043","pubmed_id":null,"openalex_id":"https://openalex.org/W7215079204","source_url":"https://doi.org/10.1016/j.psyche.2026.100043","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-10-02 01:20:19","last_checked":"2026-10-08 01:20:23","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100043","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100043","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100043","source_url":"https://doi.org/10.1016/j.psyche.2026.100043","doi":"10.1016/j.psyche.2026.100043","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5840,"title":"Exploring the therapeutic potential of psychedelics: Fear extinction mechanisms and amygdala modulation.","authors":"Kelly TJ, Liu QS","journal":"Psychedelics","publication_date":"2025-01-01","publication_year":2025,"doi":"10.61373/pp024b.0019","pubmed_id":"42440716","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42440716/","substance_tags":"psilocybin,psilocin","topic_tags":"PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-08-09 08:28:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:42440716","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42440716/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42440716","source_url":"https://pubmed.ncbi.nlm.nih.gov/42440716/","doi":"10.61373/pp024b.0019","pmid":"42440716","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5788,"title":"Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review","authors":"Nicholas Vucak, Raimondo Bruno, Julio Quealy, James G. Casimaty, Susan L. Rossell, D Castle, Nicola Acevedo","journal":"Psychedelics","publication_date":"2026-07-26","publication_year":2026,"doi":"10.1016/j.psyche.2026.100030","pubmed_id":null,"openalex_id":"https://openalex.org/W7171322300","source_url":"https://doi.org/10.1016/j.psyche.2026.100030","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Clinical Trial,Randomized Controlled Trial,Review Article,Safety,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:00","last_checked":"2026-08-09 08:25:00","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100030","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100030","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.psyche.2026.100030","source_url":"https://doi.org/10.1016/j.psyche.2026.100030","doi":"10.1016/j.psyche.2026.100030","pmid":"","publication_date":"2026-07-26","importer_version":"2.1.3","text_redistributed":false}},{"id":5770,"title":"Retreat from racism: A psychedelic group experience for racial stress and trauma","authors":"Sergio R Pérez Rosal, Sonya Faber, M. Myriah MacIntyre, Monnica Williams","journal":"Psychedelics","publication_date":"2026-07-30","publication_year":2026,"doi":"10.1016/j.psyche.2026.100031","pubmed_id":null,"openalex_id":"https://openalex.org/W7171783611","source_url":"https://doi.org/10.1016/j.psyche.2026.100031","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Neuroplasticity,Mechanism of Action,Wellbeing,Spirituality,Psychological Flexibility,Observational Study,Safety,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-03 01:20:22","last_checked":"2026-08-09 08:24:59","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100031","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100031","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.psyche.2026.100031","source_url":"https://doi.org/10.1016/j.psyche.2026.100031","doi":"10.1016/j.psyche.2026.100031","pmid":"","publication_date":"2026-07-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5733,"title":"Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement","authors":"Pérez Rosal Sergio R., Faber Sonya C.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100029","pubmed_id":null,"openalex_id":"https://openalex.org/W7169607828","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","substance_tags":"psilocybin","topic_tags":"Observational Study","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-19 01:20:13","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100029","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100029","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100029","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","doi":"10.1016/j.psyche.2026.100029","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4241,"title":"Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents","authors":"Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta, Ana María Ortiz Bernal, Christopher Timmermann, Alan K. Davis","journal":"Psychedelics","publication_date":"2025-11-15","publication_year":2025,"doi":"10.1016/j.psyche.2025.100004","pubmed_id":null,"openalex_id":"https://openalex.org/W4416229038","source_url":"https://doi.org/10.1016/j.psyche.2025.100004","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Addiction,Receptor Pharmacology,Emotional Processing,Observational Study,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:38","last_checked":"2026-08-09 08:25:15","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2025.100004","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.psyche.2025.100004","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.psyche.2025.100004","source_url":"https://doi.org/10.1016/j.psyche.2025.100004","doi":"10.1016/j.psyche.2025.100004","pmid":"","publication_date":"2025-11-15","importer_version":"2.1.3","text_redistributed":false}},{"id":4235,"title":"Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience","authors":"Stacey B. Armstrong, Meghan DellaCrosse, Jaime Fuentes-Balderrama, Rafaelle Lancelotta, Alan K. Davis","journal":"Psychedelics","publication_date":"2025-11-20","publication_year":2025,"doi":"10.1016/j.psyche.2025.100006","pubmed_id":null,"openalex_id":"https://openalex.org/W7106133965","source_url":"https://doi.org/10.1016/j.psyche.2025.100006","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Chronic Pain,Mystical Experience,Observational Study,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:38","last_checked":"2026-08-09 08:25:15","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2025.100006","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.psyche.2025.100006","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.psyche.2025.100006","source_url":"https://doi.org/10.1016/j.psyche.2025.100006","doi":"10.1016/j.psyche.2025.100006","pmid":"","publication_date":"2025-11-20","importer_version":"2.1.3","text_redistributed":false}},{"id":4234,"title":"Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reports","authors":"Holly Hepburn, Bart Ellenbroek, Jiun Youn","journal":"Psychedelics","publication_date":"2025-11-20","publication_year":2025,"doi":"10.1016/j.psyche.2025.100005","pubmed_id":null,"openalex_id":"https://openalex.org/W4416420447","source_url":"https://doi.org/10.1016/j.psyche.2025.100005","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Drug Interactions","study_type":"Qualitative Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:38","last_checked":"2026-08-09 08:25:15","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2025.100005","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.psyche.2025.100005","source_url":"https://doi.org/10.1016/j.psyche.2025.100005","doi":"10.1016/j.psyche.2025.100005","pmid":"","publication_date":"2025-11-20","importer_version":"2.1.3","text_redistributed":false}},{"id":3113,"title":"Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model","authors":"Albertyn Christopher P., Richard Jérémie, Shore Ron, Carlson Linda E.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100032","pubmed_id":null,"openalex_id":"https://openalex.org/W7171862645","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","substance_tags":"psilocybin","topic_tags":"Cancer Patients","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 11:03:46","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100032","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100032","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100032","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","doi":"10.1016/j.psyche.2026.100032","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":891,"title":"Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder.","authors":"Zhu X, Zhang C, Hellerstein D, Feusner JD, Wheaton MG, Gomez GJ, Schneier F","journal":"Psychedelics","publication_date":"2025-01-01","publication_year":2025,"doi":"10.61373/pp024r.0028","pubmed_id":"40458078","openalex_id":"https://openalex.org/W4404286681","source_url":"https://pubmed.ncbi.nlm.nih.gov/40458078/","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Receptor Pharmacology,Aging","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:40458078","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40458078/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40458078","source_url":"https://pubmed.ncbi.nlm.nih.gov/40458078/","doi":"10.61373/pp024r.0028","pmid":"40458078","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":11,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Psychedelics","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}